Study of CP-461 in Patients With Advanced Renal Cell Cancer

Clinical trial NCT00036036 · COMPLETED

Trial details

NCT number: NCT00036036
Sponsor: Astellas Pharma Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Renal Cell Carcinoma

Start date: 2001-07-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.